IFNG and infection: Our cross-sectional study clearly demonstrated that SARS-CoV-2 specific IL-2-producing T cells are maintained up to 12 months after vaccination or infection, although antibody levels and IFN-γ-producing T cells decline over time in allogeneic HCT recipients.